Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01706991 · ClinicalTrials.gov registry record
Amblyopia and Strabismus Detection Using a Pediatric Vision Scanner
A clinical trial of Amblyopia and Strabismus, sponsored by Rebiscan.
- Completed
- Registry status
- 32
- Enrollment target
- 1
- Study location
NCT01706991: Completed study of Amblyopia and Strabismus, sponsored by Rebiscan.
NCT01706991 is a study of Amblyopia and Strabismus that has completed, run by Rebiscan. The registered enrollment target is 32 participants, below the 164-participant average among 24 other Amblyopia trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01706991, a study of Amblyopia and Strabismus, has completed, sponsored by Rebiscan.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this project is to compare the performance of the Pediatric Vision Scanner (PVS) with the Gold Standard Examination to determine the effectiveness of the PVS at detecting amblyopia and strabismus. All tests and observations will be done at a single visit over the course of approximately 30 minutes.
Conditions Studied
Interventions
- DEVICE Pediatric Vision Scanner eye scan
Study Locations (1)
California
- Doheny Eye Institute - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2011-01 |
| Est. Completion | 2011-06 |
What the finished NCT01706991 record still lists
NCT01706991 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 164-participant average among 24 other Amblyopia trials with a reported enrollment target (80% lower).
The record links to 2 conditions, with Amblyopia appearing as the primary indexed condition, and to 1 intervention - of which Pediatric Vision Scanner eye scan is the first listed.
NCT01706991 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01706991 about?
NCT01706991 is a clinical study titled "Amblyopia and Strabismus Detection Using a Pediatric Vision Scanner". The purpose of this project is to compare the performance of the Pediatric Vision Scanner (PVS) with the Gold Standard Examination to determine the effectiveness of the PVS at detecting amblyopia and strabismus. All tests and observations will be done at a single visit over the course of approximate...
What is the current status of trial NCT01706991?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2011-01. Estimated completion is 2011-06.
What conditions does trial NCT01706991 study?
This clinical trial studies the following conditions: Amblyopia, Strabismus.
What interventions are being tested in trial NCT01706991?
The interventions under investigation include: Pediatric Vision Scanner eye scan (DEVICE).
Who is sponsoring clinical trial NCT01706991?
This trial is sponsored by Rebiscan, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01706991 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Amblyopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01706991's enrollment target sits among peer trials
32 20th of 24 higher than 5 of 24 other Amblyopia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Amblyopia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Noninvasive Brain Stimulation in Adult Amblyopia
RECRUITING · NA
-
OCT Eccentric Fixation and Amblyopia in Children
RECRUITING · NA
-
Visual Function Abnormalities in Strabismus and Amblyopia and Response to Therapy
RECRUITING
-
A Randomized Trial to Evaluate Sequential vs Simultaneous Patching
RECRUITING · Phase 3
-
Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age
RECRUITING · Phase 3
-
Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia